We're Here for You!

The International Myeloma Foundation (IMF) is proud to announce the recipients of this year’s Robert A. Kyle Achievement Award and Brian G.M. Durie Outstanding Achievement Award, which was presented in an in-person awards ceremony on June 8, Thursday at the 14th Annual International Myeloma Working Group (IMWG) Summit in Frankfurt, Germany. This year’s Robert A. Kyle Lifetime Achievement Awardee is Maria-Victoria Mateos, MD, PhD, Head of Myeloma and Clinical Trials Unit at the Haematology Department and Professor of Medicine at the University of Salamanca, Spain. This year’s Brian G.M. Durie Outstanding Achievement Awardee is Thomas G. Martin, III MD, Professor of Clinical Medicine; Associate Chief of Adult Hematology, Blood Marrow Transplantation and Cell Therapy (HBC); Co-Director of the Myeloma Program; and Clinical Research Director of Hematologic Malignancies at UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF) Medical Center in San Francisco, California. The Kyle and Durie Achievement Awards are presented each year to outstanding and deserving individuals who have made significant contributions in the field of myeloma research. READ NOW.

Join the IMWG Conference Series, “Making Sense of Treatment” on Thursday, June 15, 2023 at 9:00 a.m. PST / 12:00 p.m. EST. During this webinar, leading myeloma experts will discuss the latest drug therapy news from the June 2023 American Society of Clinical Oncology (ASCO) Annual Conference, IMF IMWG Summit, and the European Hematology Association (EHA) Annual Conference. IMF Chairman of the Board and Chief Scientific Officer Dr. Brian G.M. Durie will moderate the discussion, with Drs. María V. Mateos (University of Salamanca—Salamanca, Spain) and Thomas Martin (University of California San Francisco—San Francisco, CA) as panelists.   
  
Dr. Durie will open the session by discussing the large number of myeloma abstracts from the ASCO and EHA annual conferences this year. He will then share highlights from the IMF IMWG Summit. Topics for the panel include advances in immunotherapies (CAR T-cell and bispecific therapies), minimal residual disease (MRD) in myeloma, managing early and later relapse in patients, the use of mass spectrometry in assessing patient outcomes, and more. REGISTER NOW.

This IMF M-Power Workshop will take place on Saturday, June 17, 2023, from 10 a.m. EST – 12:40 p.m. EST at the Riverside Church (490 Riverside DrIve) in New York, NY 10027. This workshop’s panel of myeloma experts will be IMF Chief Medical Officer Joseph Mikhael, MD; Saad Usmani, MD; and IMF Nurse Leadership Board member Amy Pierre, MSN, RN, ANP-BC. Topics include the Importance of Communication in your Care, Changing the Course of Myeloma in New York, an Interview with Patient and Care Partner Team: Terrence and Toni Green, and Looking to the Future with Hope. Participants will also have the chance to ask these experts their questions. Register now before it’s too late!  REGISTER NOW.

This IMF M-Power Community Workshop will take place on Saturday, June 17, 2023, from 10 a.m. EST – 12:40 p.m. EST at Grace Baptist Church (52 S. 6th Avenue) in Mount Vernon, New York, NY 10550. At this location, attendees can connect with the local community and watch a livestream of the Riverside Church panel event. All will have an opportunity to ask questions in-person of two experts from New York’s Memorial Sloan Kettering Cancer Center. Those experts are Drs. Hani Hassoun and Carlyn Rose Tan. Register now to engage with your local community! Seats are limited. REGISTER NOW.

Join Las Voces de Mieloma Support Group  (Spanish/Virtual), on  Tuesday, June 20, 10:00 a.m.–11:00 a.m. (Pacific) with Guest speaker: Cesar Rodriguez, MD, Associate Professor of Medicine at the Icahn School of Medicine at Mount Sinai and Clinical Director of the Multiple Myeloma Center of Excellence. For any questions, please email [email protected]. LEARN MORE.

Las Voces de Mieloma Grupo de Apoyo (en Español/Virtual), Martes, 20 de Junio, 10:00 a.m.—11:00 a.m. (Tiempo Pacífico) con Invitada Especial: Dr. Cesar Rodriguez, Profesor Asociado de Medicina en la Escuela de Medicina Icahn en Mount Sinai y Director Clínico del Centro de Excelencia en Mieloma Múltiple. Para preguntas, envíe un correo electrónoco a: [email protected]. APRENDE MÁS.

The Brian D. Novis Research Grant was established in 1995 to honor IMF co-founder Brian D. Novis, who succumbed to multiple myeloma in July 1992. The grants are awarded to researchers working in the field of multiple myeloma and related disorders, including smoldering multiple myeloma (SMM), monoclonal gammopathy of undetermined significance (MGUS), and immunoglobulin-derived amyloidosis. The grants will support senior research projects with $80,000 each and junior research projects with $50,000 each. Deadline for submission of applications is August 28, 2023.  LEARN MORE.